✦ LIBER ✦

Temporal distribution of treatment to reperfusion times in patients with acute myocardial infarction receiving streptokinase or tissue plasminogen activator

✍ Scribed by Prediman K. Shah; Allan S. Lew; Bojan Cercek; William Ganz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tissue plasminogen activator was cost-ef

✍ David M. Kent; Sandeep Vijan; Rodney A. Hayward; John L. Griffith; Joni R. Besha 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 433 KB

Thrombolysis with tissue plasminogen act

✍ Paassilta, M.; Kervinen, K.; Peuhkurinen, K.J.; Kesäniemi, Y.A. 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 652 KB

Prognostic role of plasminogen—activator

✍ Andreta Sinkovič 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB

Platelet Activity in the Early Stage of

✍ Alessandro Salvioni; Giovanni B. Perego; Giancarlo Marenzi; Stefano Galli; Emili 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 187 KB

Efegatran sulfate as an adjunct to strep

✍ Anthony Y. Fung; Gerald Lorch; Patrick A. Cambier; Dennis Hansen; Bradley G. Tit 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Efficacy of Streptokinase, but Not Tissu

✍ P.Gabriel Steg; Thierry Laperche; Jean-Louis Golmard; Jean-Michel Juliard; Hakim 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 95 KB